Therapeutic potentials of nonpeptidic V2R agonists for partial cNDI-causing V2R mutants. Kuramoto R, Kise R, Kanno M, Kawakami K, et al. PLoS One 2024;19:e0303507.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kuramoto R, Kise R, Kanno M, Kawakami K, et al. Therapeutic potentials of nonpeptidic V2R agonists for partial cNDI-causing V2R mutants. PLoS One 2024;19:e0303507.
PMID: 38748623